A pressing health crisis looms over Hungary as cardiovascular disease claims 42% of national mortality, surpassing the EU average by a significant margin. This alarming statistic is particularly troubling given that nearly half of these cases could be prevented through improved management of high LDL cholesterol levels. The gravity of the situation is underscored by the fact that hereditary factors, not just lifestyle choices, contribute to elevated cholesterol levels, often without the individual's knowledge. Despite the life-saving potential of early detection and appropriate treatment, there is a concerning lack of engagement with screening tests. This disconnects between the severity of the issue and the low uptake of preventive measures highlights a critical need for increased awareness and proactive healthcare initiatives in Hungary. By addressing this gap, the nation could dramatically reduce cardiovascular-related deaths and improve the overall health of its population.

In a strategic partnership with Novartis, we orchestrated comprehensive cardiovascular screening programmes in Győr, Szeged, and Székesfehérvár to commemorate World Heart Day. The initiative encompassed a multi-tiered approach, beginning with basic complementary tests and finger-prick blood screenings to identify potential at-risk individuals. Those flagged for concern were then directed to private health professionals for more complex evaluations, including risk assessment questionnaires and specialized tests, culminating in personalized cardiologist consultations for high-risk cases. Concurrently, we launched a media campaign to educate the public about the hereditary aspects of cardiovascular diseases and high cholesterol, emphasizing the critical importance of early detection and treatment. This holistic approach not only provided immediate health interventions but also aimed to foster long-term public health awareness, underscoring Novartis' commitment to addressing the pressing issue of cardiovascular health through both direct action and sustained public engagement.

The programme, launched last year in Győr, Székesfehérvár, and Szeged, has demonstrated significant impact in addressing cardiovascular health priorities. With 1,045 individuals screened and 526 referred for further testing, the initiative has proven its effectiveness in early detection and intervention. Building on this success, the programme is set to continue in Szeged, Nyíregyháza and Újbuda this year, leveraging partnerships with local governments to expand its reach. The campaign's comprehensive media strategy, including 5 press releases, 4 interviews, 4 native articles, videos and 2 radio ads during the two months generated 15 coverage across regional and national outlets, effectively bringing cardiovascular health issues into public discourse. These concerted efforts, the programme not only raised awareness about the prevalence of cardiovascular diseases in Hungarian society but also positioned Novartis as a key solution provider in addressing this critical health concern.